Suit: Pfizer/Wyeth sought black patients for unsafe drug
Pfizer’s $68 billion acquisition of Wyeth last year has turned into a full-employment act for the drugmaker’s outside law firms. Yesterday the company was slapped with a whistleblower lawsuit alleging Wyeth detailers promoted the off-label use of the immunosuppressant drug Rapamune for kidney transplant patients even though the Food and Drug Administration has explicitly warned […]